A recently filed patent (Publication Number: US20230263735A1) describes a film-coated tablet with specific compositions and properties. The tablet consists of a core tablet coated with two film layers ...
CAMBRIDGE, England, June 02, 2026--(BUSINESS WIRE)--Cycle Pharmaceuticals (Cycle) announces the FDA approval of CAVHANZA (nilotinib) Orally Disintegrating Tablets. Launching soon, the CAVHANZA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results